Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ptc Therapeutics (NQ: PTCT )

31.79 -1.17 (-3.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 512,539
Open 33.16
Bid (Size) 31.00 (6)
Ask (Size) 45.00 (1)
Prev. Close 32.96
Today's Range 31.70 - 33.30
52wk Range 17.53 - 59.84
Shares Outstanding 76,696,785
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
PTC Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 61 to 72. 
Via Investor's Business Daily
PTCT Stock Earnings: PTC Therapeutics Beats EPS, Beats Revenue for Q1 2024
PTCT stock results show that PTC Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+13.37%
+13.37%
1 Month
+18.27%
+18.27%
3 Month
+18.66%
+18.66%
6 Month
+56.91%
+56.91%
1 Year
-42.77%
-42.77%

More News

Read More
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: PTC Therapeutics Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Earnings Preview: PTC Therapeutics
Via Benzinga
Analyst Expectations for PTC Therapeutics's Future
Via Benzinga
Earnings Preview: PTC Therapeutics
Via Benzinga
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
Via The Motley Fool
PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug
Via Investor's Business Daily
PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
Via Benzinga
ALGN Stock Alert: Align Technology Announces $250M Stock Buyback Program
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
RBLX Stock Alert: Analysts Are Pounding the Table on Roblox
Via InvestorPlace
Why Is PTC Therapeutics (PTCT) Stock Down 23% Today?
Via InvestorPlace
Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why PTC Therapeutics Soared 15% Higher Today
Via The Motley Fool
Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.